Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Biochemical Society Transactions
|
May 1, 1994
The activities of cathepsins B, D and H in the hearts of rats treated with ethanol
T Siddiq, D K Shori, G B Proctor, et al.
Neuroscience Letters
|
May 2, 2002
Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease
M E Götz, M Wacker, C Luckhaus, et al.
American Journal of Medical Genetics
|
May 7, 2002
Estrogen receptor 1 gene (ESR1) variants in panic disorder
P G Sand, K Schlurmann, C Luckhaus, et al.
European Journal of Neurology
|
May 7, 2010
A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables
C Luckhaus, M Jänner, M Cohnen, et al.
Der Nervenarzt
|
December 16, 2004
[Data supporting quality circle management of inpatient depression treatment]
S Brand, M Härter, P Sitta, et al.
The Journal of Nutrition, Health & Aging
|
June 5, 2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI
O Peters, D Lorenz, A Fesche, et al.
Neurology
|
January 13, 2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
M Wagner, S Wolf, F M Reischies, et al.
The Journal of Nutrition, Health & Aging
|
March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment
K Blennow, G De Meyer, O Hansson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Biochemical Society Transactions
|
May 1, 1994
The activities of cathepsins B, D and H in the hearts of rats treated with ethanol
T Siddiq, D K Shori, G B Proctor, et al.
Neuroscience Letters
|
May 2, 2002
Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease
M E Götz, M Wacker, C Luckhaus, et al.
American Journal of Medical Genetics
|
May 7, 2002
Estrogen receptor 1 gene (ESR1) variants in panic disorder
P G Sand, K Schlurmann, C Luckhaus, et al.
European Journal of Neurology
|
May 7, 2010
A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables
C Luckhaus, M Jänner, M Cohnen, et al.
Der Nervenarzt
|
December 16, 2004
[Data supporting quality circle management of inpatient depression treatment]
S Brand, M Härter, P Sitta, et al.
The Journal of Nutrition, Health & Aging
|
June 5, 2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI
O Peters, D Lorenz, A Fesche, et al.
Neurology
|
January 13, 2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
M Wagner, S Wolf, F M Reischies, et al.
The Journal of Nutrition, Health & Aging
|
March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment
K Blennow, G De Meyer, O Hansson, et al.
Page
of 2